In vivo behaviour of a biodegradable poly (trimethylene carbonate) barrier membrane: A histological study in rats

Department of Oral and Maxillofacial Surgery, University Medical Center Groningen, Groningen, The Netherlands.
Journal of Materials Science Materials in Medicine (Impact Factor: 2.59). 05/2012; 23(8):1951-9. DOI: 10.1007/s10856-012-4663-x
Source: PubMed


The aim of the present study was to evaluate the response of surrounding tissues to newly developed poly(trimethylene carbonate) (PTMC) membranes. Furthermore, the tissue formation beneath and the space maintaining properties of the PTMC membrane were evaluated. Results were compared with a collagen membrane (Geistlich BioGide), which served as control. Single-sided standardized 5.0 mm circular bicortical defects were created in the mandibular angle of rats. Defects were covered with either the PTMC membrane or a collagen membrane. After 2, 4 and 12 weeks rats were sacrificed and histology was performed. The PTMC membranes induced a mild tissue reaction corresponding to a normal foreign body reaction. The PTMC membranes showed minimal cellular capsule formation and showed signs of a surface erosion process. Bone tissue formed beneath the PTMC membranes comparable to that beneath the collagen membranes. The space maintaining properties of the PTMC membranes were superior to those of the collagen membrane. Newly developed PTMC membranes can be used with success as barrier membranes in critical size rat mandibular defects.

Download full-text


Available from: Rudolf R M Bos, Sep 12, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Introduction: Chronic osteomyelitis, or bone infection, is a major worldwide cause of morbidity and mortality, as it is exceptionally hard to treat due to patient and pathogen-associated factors. Successful treatment requires surgical debridement together with long-term, high antibiotic concentrations that are best achieved by local delivery devices, either made of degradable or non-degradable materials. Areas covered: Non-degradable delivery devices are frequently constituted by polymethylmethacrylate-based carriers. Drawbacks are the need to remove the carrier (as the carrier itself may provide a substratum for bacterial colonization), inefficient release kinetics and incompatibility with certain antibiotics. These drawbacks have led to the quest for degradable alternatives, but also devices made of biodegradable calcium sulphate, collagen sponges, calcium phosphate or polylactic acids have their specific disadvantages. Expert opinion: Antibiotic treatment of osteomyelitis with the current degradable and non-degradable delivery devices is effective in the majority of cases. Degradable carriers have an advantage over non-degradable carriers that they do not require surgical removal. Synthetic poly(trimethylene carbonate) may be preferred in the future over currently approved lactic/glycolic acids, because it does not yield acidic degradation products. Moreover, degradable poly(trimethylene carbonate) yields a zero-order release kinetics that may not stimulate development of antibiotic-resistant bacterial strains due to the absence of long-term, low-concentration tail-release.
    Expert Opinion on Drug Delivery 01/2013; 10(3). DOI:10.1517/17425247.2013.751371 · 4.84 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In oral and maxillofacial surgery, guided bone regeneration using barrier membranes is an important strategy to treat bone defects. The currently used barrier membranes have important disadvantages. Barrier membranes prepared from resorbable poly(trimethylene carbonate) (PTMC) performed as well as collagen barrier membranes. We hypothesized that composite membranes prepared from surface-eroding PTMC and osteoinductive biphasic calcium phosphate (BCP) would enhance bone formation even further. Bicortical critical size defects in the mandibular angle of rats were covered on both sides with the membranes. After 2, 4, and 12 weeks the extent of bone formation in the defects and the soft tissue reaction towards the membranes was examined histologically. At 2 and 4 weeks, the formation of new bone was observed in defects covered with PTMC, PTMC-BCP and Biogide collagen membranes. At 12 weeks, bone defects that were covered with PTMC membranes and control Biogide collagen membranes were fully filled with new formed bone. However, at this time point, defects covered with PTMC-BCP composite membranes had not led to new bone in the defects. Instead a significant tissue reaction, likely to remaining BCP particles, was observed.
    Macromolecular Symposia 12/2013; 334(1). DOI:10.1002/masy.201300103
  • [Show abstract] [Hide abstract]
    ABSTRACT: The drug-eluting stent (DES) is the most common means for the treatment of severe coronary heart disease in the clinic. However the DES has some drawbacks, these are long-term endothelial dysfunction, non selective cytotoxicity and late stent thrombosis. Hence, it is significantly important to find a drug or molecule with selective cytotoxicity for the DES. In this work, the effect of gradient concentration of gallic acid on endothelial and smooth muscle cells was investigated through alone-culture and co-culture methods. It was demonstrated that gallic acid promoted the growth of human umbilical vein endothelial cells (HUVECs) and suppressed the proliferation of human umbilical artery smooth muscle cells (HUASMCs) at the concentration of 5 μg ml−1. Then, gallic acid was mixed into poly(1,3-trimethylene carbonate) to prepare GA-loaded PTMC film via solvent evaporation. And material characteristics and biological evaluations are carried out by different means. These results showed that the GA-loaded PTMC film inhibited the adhesion and activation of platelets, indicating a good anticoagulant performance. Also, this film with a certain GA loading (1 wt%) provided significant enhancement for the adhesion and proliferation of HUVECs and inhibition of the growth of HUASMCs. These data suggested the large potential of GA for drug-eluting stent and other vascular devices.
    RSC Advances 01/2014; 4(1):212. DOI:10.1039/c3ra44217a · 3.84 Impact Factor
Show more